{
    "organizations": [],
    "uuid": "5fd0a24d824bb07324cff5dbcb5b50c383262f3a",
    "author": "",
    "url": "https://www.reuters.com/article/brief-apricus-biosciences-says-co-receiv/brief-apricus-biosciences-says-co-received-a-nasdaq-staff-deficiency-letter-idUSFWN1RT0T5",
    "ord_in_thread": 0,
    "title": "BRIEF-Apricus Biosciences Says Co Received A Nasdaq Staff Deficiency Letter",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 16, 2018 / 8:17 PM / Updated 5 minutes ago BRIEF-Apricus Biosciences Says Co Received A Nasdaq Staff Deficiency Letter Reuters Staff 1 Min Read \nApril 16 (Reuters) - Apricus Biosciences Inc: \n* APRICUS BIOSCIENCES SAYS ON APRIL 10, CO RECEIVED A NASDAQ STAFF DEFICIENCY LETTER - SEC FILING Source : bit.ly/2JMowAJ Further company coverage: (Reuters.Briefs@thomsonreuters.com)",
    "published": "2018-04-16T23:16:00.000+03:00",
    "crawled": "2018-04-16T23:31:31.024+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "pm",
        "updated",
        "minute",
        "ago",
        "bioscience",
        "say",
        "co",
        "received",
        "nasdaq",
        "staff",
        "deficiency",
        "letter",
        "reuters",
        "staff",
        "min",
        "read",
        "april",
        "reuters",
        "apricus",
        "bioscience",
        "inc",
        "apricus",
        "bioscience",
        "say",
        "april",
        "co",
        "received",
        "nasdaq",
        "staff",
        "deficiency",
        "letter",
        "sec",
        "filing",
        "source",
        "company",
        "coverage"
    ]
}